OnPremClinicalLlmDeployment Agent

<!--
# COPYRIGHT NOTICE
# This file is part of the "Universal AI Agentic Skills" project.
# Copyright (c) 2026 MD BABU MIA, PhD <md.babu.mia@mssm.edu>
# All Rights Reserved.
#
# This code is proprietary and confidential.
# Unauthorized copying of this file, via any medium is strictly prohibited.
#
# Provenance: Authenticated by MD BABU MIA
-->



<!-- AUTHOR_SIGNATURE: 9a7f3c2e-MD-BABU-MIA-2026-MSSM-SECURE -->

---
name: 'on-prem-clinical-llm-deployment'
description: 'Plan and validate on-prem clinical LLM deployments for distilled open-source diagnosis models, balancing performance, privacy, hardware, governance, and human oversight.'
measurable_outcome: 'Execute skill workflow successfully with valid output within 15 minutes.'
allowed-tools:
  - read_file
  - run_shell_command
  - web_fetch
---

# On-Prem Clinical LLM Deployment

## Overview

Use this skill to decide whether an on-premises clinical LLM deployment is appropriate and to design a validation and governance plan before use in diagnosis-support workflows. It is grounded in evidence that distilled open-source DeepSeek-R1-style models can create practical tradeoffs for clinical deployment, especially around local performance, privacy, hardware constraints, validation burden, and human oversight. Treat model output as decision support only, with licensed clinicians retaining responsibility for patient care.

## When to Use This Skill

- Evaluate distilled or open-source medical LLMs for on-premises clinical use.
- Compare local deployment against hosted frontier model options for diagnosis support.
- Plan validation for PHI-sensitive clinical workflows before production release.
- Assess GPU, latency, storage, monitoring, availability, and cost constraints.
- Define governance, audit, incident-response, and rollback controls for a clinical AI service.
- Prepare human-oversight procedures for model uncertainty, escalation, and clinician review.

## Core Capabilities

1. Deployment suitability assessment: Clarify whether on-prem deployment is justified by privacy, network isolation, institutional policy, latency, cost, or availability requirements.
2. Model comparison workflow: Compare candidate local models against hosted frontier alternatives using the same clinical task definitions, datasets, prompts, and review criteria.
3. Clinical validation plan: Define retrospective testing, shadow evaluation, clinician adjudication, subgroup analysis, failure review, and acceptance criteria without inventing unsupported benchmark claims.
4. Infrastructure planning: Estimate hardware, quantization, inference server, scaling, backup, monitoring, and maintenance needs for local operation.
5. Privacy and security controls: Map PHI handling, access control, audit logging, de-identification, retention, encryption, and network boundaries.
6. Governance and documentation: Produce model cards, data lineage notes, change-control records, risk registers, and release checklists appropriate for clinical operations.
7. Human oversight design: Specify clinician-in-the-loop review, uncertainty disclosure, contraindication handling, escalation paths, and limits on autonomous diagnostic use.
8. Post-deployment monitoring: Track drift, degraded performance, unsafe outputs, downtime, user feedback, prompt changes, and incident triggers after release.
9. Distilled DeepSeek-R1 case-study assessment: Document quantization settings and hardware constraints; evaluate diagnostic accuracy, calibration, and throughput; preserve reproducibility artifacts; verify privacy controls; track exact model versions; and enforce human-review gates without assuming unsupported benchmark results.
10. Evidence-based compact-model gate: Validate diagnostic performance of distilled DeepSeek-R1 candidates before deployment; treat distillation and quantization as potential clinical-performance risks; select model size and precision against available hardware; document the privacy benefit of keeping clinical data local; test relevant patient subgroups; and reject deployment when a compact model underperforms predefined clinical acceptance criteria or the selected comparator.
11. On-prem diagnosis comparison gate: Benchmark locally hosted distilled or open-source candidates against closed/provider models before deployment; document hardware requirements and privacy tradeoffs; include specialty-stratified diagnostic performance checks; and require human oversight plus rollback criteria for on-prem clinical use.
12. Distilled DeepSeek-R1 diagnosis validation case: Use the 2026 clinical diagnosis comparison as a case for selecting appropriate benchmarks, running privacy-preserving local inference, documenting performance tradeoffs versus hosted frontier models, sizing on-prem hardware, and requiring clinician oversight before any diagnostic use.
13. Comparative diagnosis evidence gate: Use the 2026 J Med Syst finding on distilled DeepSeek-R1 open-source diagnosis models to require model-selection tradeoff review, privacy and hardware-constraint documentation, diagnosis-performance validation against defined comparators, failure analysis of incorrect or unsafe diagnostic outputs, and explicit governance approval before any clinical use.
14. Distilled open-source diagnosis deployment checks: For on-prem DeepSeek-R1-distilled or similar open-source diagnosis models, require comparative performance review, hardware and privacy constraint assessment, explicit model-selection rationale, predefined validation thresholds, and human oversight before clinical use.
15. Distilled reasoning model deployment caution: Benchmark smaller distilled DeepSeek-R1 or open-source diagnostic candidates against closed-model comparators before on-prem deployment; document privacy benefits, infrastructure limits, and local model governance; require human clinical review; and warn that deployment convenience does not establish diagnostic adequacy because smaller distilled reasoning models may underperform in clinical diagnosis.
16. Privacy-preserving local diagnosis evaluation case: Use the 2026 distilled DeepSeek-R1 on-prem clinical deployment comparison to assess hardware-performance tradeoffs, model-selection cautions, governance checkpoints, and required human oversight before relying on local diagnosis-support outputs.
17. Comparative distilled DeepSeek-R1 validation case: Use the 2026 PubMed-indexed comparative study of open-source distilled DeepSeek-R1 medical diagnosis models as a validation case, not proof of production readiness; document hardware and privacy tradeoffs, benchmark design and comparator selection, local model governance, diagnosis safety gates for incorrect or unsafe outputs, and explicit clinician oversight before production use.
18. Distilled open-source diagnosis benchmark gate: For on-prem DeepSeek-R1-distilled or other open-source diagnosis models, design comparator benchmarks before selection, record diagnostic performance caveats, weigh privacy benefits against local hardware limits, validate the exact local model and serving configuration, and require human oversight gates before clinical use.
19. Comparative on-prem diagnosis deployment guidance: For distilled DeepSeek-R1 or similar open-source diagnosis models, require documented model-selection rationale, privacy-versus-hardware tradeoff review, evaluation against predefined clinical diagnosis benchmarks or comparators, hallucination and unsafe-output controls with failure review, and explicit human oversight gates before any diagnosis-support release.
20. Distilled open-source reasoning model evidence gate: Use the 2026 comparative study of distilled DeepSeek-R1-style open-source diagnosis models as evidence that on-prem candidates need validation against proprietary baselines, documented hardware and privacy tradeoffs, local governance approval, and human review gates before clinical use.
21. Distilled DeepSeek-R1 adoption triage: Before adopting distilled DeepSeek-R1 or other open-source diagnosis models on premises, run comparative performance checks on the target diagnostic tasks, document local hardware constraints and privacy rationale, calibrate confidence behavior against clinical diagnostic use cases, and route low-confidence or high-risk outputs through explicit clinician oversight gates.
22. DeepSeek-R1 distilled diagnosis comparison evidence: Treat PubMed 42062641 as evidence to benchmark model size against diagnosis performance for the exact on-prem configuration, record hardware and privacy constraints, route diagnostic-risk cases through predefined gates, and require clinician oversight before clinical use.
23. Distilled DeepSeek-R1 deployment caution: Treat benchmark degradation after distillation as a material clinical deployment risk; require specialty- and task-specific validation, PHI-safe on-prem evaluation harnesses, hardware/privacy tradeoff documentation, and governance gates before clinical use.
24. Distilled reasoning model readiness guardrail: Use the 2026 comparative study of distilled DeepSeek-R1 open-source diagnosis models to require target-environment performance validation, privacy-versus-on-prem hardware constraint review, and clinician-governed diagnostic workflows before release rather than assuming distilled reasoning models are production-ready.
25. Distilled DeepSeek-R1 substitution guard: Use PubMed 42062641 as comparative evidence for benchmark and comparator selection, not as deployment approval; document privacy benefits alongside hardware and performance tradeoffs; require local clinical validation and governance before diagnosis-support use; preserve human oversight and escalation paths; and do not treat smaller distilled models as drop-in substitutes for governed clinical decision support.
26. Distilled DeepSeek-R1 on-prem diagnosis comparison guard: Require local benchmark sets for the target diagnostic workflow, document privacy and hardware tradeoffs for the exact deployment, add clinician review gates before clinical use, and explicitly separate diagnostic assistance from autonomous diagnosis.
27. Distilled open-source reasoning deployment gate: For on-prem diagnostic settings, benchmark distilled open-source reasoning candidates against closed frontier models on the same diagnostic tasks; document privacy and hardware tradeoffs; validate locally on institution-specific cases; and require governance checkpoints before any clinical use.
28. Distilled DeepSeek-R1 comparative validation evidence: Use the 2026 J Med Syst comparative study as evidence that open-source distilled DeepSeek-R1-derived diagnosis models require validation before on-prem clinical deployment; choose benchmarks and comparators for the intended diagnostic task; document privacy benefits against diagnostic performance tradeoffs and hardware constraints; and require clinician oversight for all diagnosis-support outputs.
29. Distilled DeepSeek-R1-derived model evaluation: Treat the 2026 comparative study as evidence for diagnosis-task benchmarking of distilled DeepSeek-R1-derived open-source models before on-prem use; document privacy and security tradeoffs, local hardware constraints, and exact model provenance; and require clinician oversight before production deployment.
30. Distilled DeepSeek-R1-style deployment gating: Use PubMed 42062641 as comparative evidence to select local benchmarks and comparators for the intended diagnostic workflow, run privacy-preserving validation on the exact on-prem model configuration, document hardware/performance tradeoffs, review failure modes from incorrect diagnostic outputs, and require explicit human oversight before clinical use.
31. Comparative distilled DeepSeek-R1-derived diagnostic results gate: For on-prem candidates, document the reported paired comparisons before selection: DeepSeek-R1-671B outperformed DeepSeek-V3 on simulated diagnostic cases (95.45% vs. 88.18%; p = 0.008), DeepSeek-R1-8B underperformed Llama3.1-8B (47.27% vs. 64.54%; p = 0.003), and mid-sized distilled models showed no significant differences from their base models; treat reasoning drift, red-flag recognition failure, and diagnostic priority inversion as failure modes to review; capture GPU, memory, latency, and storage constraints together with the privacy benefit of local PHI processing; validate the exact model, prompt, quantization, and serving stack against clinician gold-standard diagnoses and real or institution-specific patient data before use; and require human oversight, escalation, and rollback for all diagnosis-support outputs.
32. Open-source diagnostic model tradeoff review: Use the 2026 PubMed comparative study on distilled DeepSeek-R1/open-source diagnosis models as evidence to require performance validation in the target clinical environment, documentation of privacy constraints, hardware sizing for the exact on-prem configuration, local governance approval, and explicit human oversight before clinical use.
33. Distilled open-source reasoning validation: Treat PubMed 42062641 as evidence that distilled open-source reasoning models need local benchmark design before on-prem clinical diagnosis deployment; compare the exact local configuration with selected hosted frontier baselines where available; document privacy and hardware tradeoffs; require human oversight gates; and report failure modes such as reasoning drift, red-flag recognition failure, and diagnostic priority inversion without treating the study as deployment approval.
34. Distilled DeepSeek-R1-derived diagnostic model evaluation evidence: Use Zhong et al. 2026 (PubMed 42062641) as comparative evidence for evaluating distilled DeepSeek-R1-derived open-source diagnostic models before on-prem clinical deployment; design benchmarks around the intended diagnostic workflow and chosen comparators; document model-selection caveats, privacy and governance tradeoffs, local hardware constraints, and required clinician oversight before production use.
35. Distilled DeepSeek-R1-style diagnostic model evaluation gate: For on-prem clinical diagnostic deployments, evaluate distilled open-source DeepSeek-R1-style candidates with benchmarks selected for the intended diagnostic workflow and chosen comparators; document privacy benefits, PHI controls, hardware capacity, latency, storage, and model-serving tradeoffs for the exact local configuration; review failure modes from incorrect, unsafe, uncertain, or unsupported diagnostic outputs; require governance controls for model approval, audit logging, change control, incident response, and rollback; and mandate clinician oversight before production use.
36. Distilled DeepSeek-R1 on-prem diagnostic evidence review: Use PubMed 42062641 as evidence to compare local open-source diagnostic model performance against deployment constraints before release; document privacy controls, hardware sizing assumptions, validation datasets, calibration checks, clinician oversight requirements, and failure-mode monitoring for the exact on-prem configuration.

## Inputs / Outputs

Inputs:

- Intended clinical workflow, users, patient population, and deployment environment.
- Candidate model names, versions, licenses, weights, quantization settings, and serving stack.
- Local hardware constraints, security requirements, PHI policy, and network boundaries.
- Evaluation dataset description, reference standard, clinician review process, and comparator models.
- Institutional risk tolerance, approval pathway, monitoring requirements, and rollback plan.

Outputs:

- On-prem deployment decision memo with assumptions, risks, and go/no-go recommendation.
- Validation protocol covering datasets, tasks, metrics, review roles, and acceptance criteria.
- Infrastructure and operations checklist for serving, monitoring, access control, and maintenance.
- Governance package outline including model card, audit plan, change log, and incident response.
- Human-oversight workflow defining allowed use, prohibited use, escalation, and final clinical accountability.

## References

- Source finding: https://pubmed.ncbi.nlm.nih.gov/42062641/
- PubMed 42062641, "Open-Source Large Language Models Distilled DeepSeek-R1 Pose Challenges for On-Premises Clinical Deployment in Medical Diagnosis: A Comparative Study of Performance.": https://pubmed.ncbi.nlm.nih.gov/42062641/
- PubMed 42062641, J Med Syst, 2026 May 1: https://pubmed.ncbi.nlm.nih.gov/42062641/
- PubMed 42062641, 2026 comparative study of distilled DeepSeek-R1 open-source diagnosis models: https://pubmed.ncbi.nlm.nih.gov/42062641/
- https://pubmed.ncbi.nlm.nih.gov/42062641/
- Source finding update: https://pubmed.ncbi.nlm.nih.gov/42062641/
- Zhong W, Fu Y, Peng D, Liu Y, Liu Y. Open-Source Large Language Models Distilled DeepSeek-R1 Pose Challenges for On-Premises Clinical Deployment in Medical Diagnosis: A Comparative Study of Performance. J Med Syst. 2026 May 1. https://pubmed.ncbi.nlm.nih.gov/42062641/
- PubMed 42062641 comparative study on distilled DeepSeek-R1-derived open-source models for on-premises clinical diagnosis deployment: https://pubmed.ncbi.nlm.nih.gov/42062641/
- Source URL: https://pubmed.ncbi.nlm.nih.gov/42062641/
- Source finding update: https://pubmed.ncbi.nlm.nih.gov/42062641/
- PubMed 42062641 source finding: https://pubmed.ncbi.nlm.nih.gov/42062641/
- https://pubmed.ncbi.nlm.nih.gov/42062641/
- https://pubmed.ncbi.nlm.nih.gov/42062641/
- https://pubmed.ncbi.nlm.nih.gov/42062641/
- https://pubmed.ncbi.nlm.nih.gov/42062641/